Bancroft Robert E.
Reporting owner on Forms 3, 4 and 5, CIK 2066370.
Bancroft Robert E. reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-20.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| AEON · AEON Biopharma, Inc.CIK 1837607 | director, officer (President and CEO) | 1 | 2026-11-20 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| AEON · AEON Biopharma, Inc.Class A Common Stock | 2026-11-19 | P bought | +152,333 | $0.1286 | 3,329,436 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0002066370-26-000002 | AEON Biopharma, Inc. | 2026-11-20 |